A*STAR recently launched a joint centre with National University of Singapore – Singapore Centre for Nutritional Sciences, Metabolic Diseases, and Human Advancement – to advance research on nutrition, early advancement and metabolic disease. This agreement will also allow Nestl – access to A*STAR's research facilities and technology. Related StoriesProper iodine diet necessary during pregnancyResearchers discover significant link between breast cancer and nutrition, explore brand-new preventative treatmentNutrition vital for patients recovering from severe burns Mr Lim Chuan Poh, Chairman of A*STAR said, ‘A*STAR is looking forward to this excellent opportunity to broaden and deepen the task that people do with the globe's leading diet and food company to broaden their R&D capabilities in Singapore.In 2011, Medicaid spent a lot more than $3.6 billion on so-called second-generation antipsychotic medicines, a category of medicines introduced in the 1990s. Five brand-name medicines – – Abilify , Seroquel , Zyprexa , Geodon , and Invega – – accounted for 90 %, or $3.3 billion, of that spending, the study found. Using forecasting models, the research team estimated that Medicaid’s annual spending on antipsychotic drugs can fall by nearly 50 %, or $1.8 billion, by 2016. Spending should drop another $2.8 billion by 2019, they predicted. The analysis was published in the journal Psychiatric Solutions recently.. ‘AIDS-free generation’ feasible with obtainable tools for prevention, but not without political will Noting that [t]he XIX International AIDS Conference [AIDS 2012] has just arrive to a close amid very much talk of the beginning of the end of AIDS, turning the tide on HIV and even a potential cure, Julio Montaner, previous president of the Worldwide AIDS Society and director of the B.C.